Biosimulation Software Innovation Certara has recently launched new versions of its Biosimulation software, showcasing a commitment to innovation in drug development technology. This presents a sales opportunity to offer the latest software solutions to biopharmaceutical companies seeking to enhance their drug discovery processes.
Expansion through Acquisition By acquiring Chemaxon Limited, Certara has expanded its product portfolio and market reach. This acquisition opens up potential sales opportunities to provide integrated solutions to a broader customer base looking for comprehensive drug development services.
Talent Investment for Board Expertise The addition of John Reynders as an independent board member signifies Certara's focus on bringing in top-tier talent for strategic decision-making. This presents a sales opportunity to leverage the expertise and networks of the new board member to enhance partnerships and collaborations within the industry.
Specialized Software Offerings Certara's launch of CoAuthor and its regulatory writing software generation demonstrates a commitment to developing specialized solutions for medical writers. This presents a sales opportunity to cater to the needs of organizations looking for advanced writing platforms in the healthcare sector.
Market-Leading Drug Development Solutions With a strong presence in model-informed drug development and a wide client base across 62 countries, Certara is well-positioned to offer market-leading solutions. This presents a sales opportunity to capitalize on Certara's reputation and expertise to secure contracts with biopharmaceutical companies and regulatory agencies globally.
10K
$1B
75K$1B
10K$1B
10K$1B
44$10M
23K$1B
15K$1B
5.7K$1B
21K$1B
64$10MCertara uses 8 technology products and services including Ansible, Cloudflare, CircleCI, and more. Explore Certara's tech stack below.
| Certara Email Formats | Percentage |
| First.Last@certara.com | 95% |
| FLast@certara.com | 4% |
| First_Last@certara.com | 1% |
Business Consulting and ServicesPennsylvania, United States1001-5000 Employees
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
Company Overview
Media & News
Funding & FinancialsCertara's revenue is in the range of $100M$1B
Funding & FinancialsCertara's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com